Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Two-step interferon rebound therapy for refractory chronic hepatitis C].

M Kato1, N Yuki, A Kaneko

  • 1Department of Gastroenterology, Osaka National Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 10, 2001
PubMed
Summary

Hepatitis C virus (HCV) RNA levels often rebound after interferon (IFN) treatment. Two-step interferon rebound therapy (TIRT) may improve outcomes for non-responsive patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Propofol infusions using a human target controlled infusion (TCI) pump in chimpanzees (Pan troglodytes).

Scientific reports·2021
Same author

T-cell/Histiocyte-rich Large B-cell Lymphoma of the Larynx in a Juvenile Japanese Macaque (Macaca fuscata).

Journal of comparative pathology·2019
Same author

Public health and healthcare-associated risk of electric, warm-water bidet toilets.

The Journal of hospital infection·2017
Same author

Surveillance for malaria outbreak on malaria-eliminating islands in Tafea Province, Vanuatu after Tropical Cyclone Pam in 2015.

Epidemiology and infection·2016
Same author

Transient receptor potential ankyrin 1 agonists improve intestinal transit in a murine model of postoperative ileus.

Neurogastroenterology and motility·2016
Same author

Characterization of spontaneous malignant lymphomas in Japanese macaques (Macaca fuscata).

Veterinary pathology·2014

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Interferon (IFN) therapy is a standard treatment for Hepatitis C virus (HCV) infection.
  • Many patients do not achieve sustained virologic response (SVR) with standard IFN treatment.
  • HCV RNA levels frequently rebound after IFN discontinuation.

Observation:

  • HCV RNA levels often rebound after interferon treatment cessation.
  • Rebound in HCV RNA can lead to transient transaminase elevation.
  • HCV RNA levels decrease after transient exacerbation.

Findings:

  • Two-step interferon rebound therapy (TIRT) involves additional IFN administration during HCV RNA decrease.
  • TIRT has shown promise in treating type 1b HCV patients with high viral loads unresponsive to initial IFN.

Related Experiment Videos

  • Health insurance coverage for additional IFN administration was established in 2000.

    • Implications:

    • TIRT may enhance treatment efficacy in non-responsive HCV patients.
    • Further research into TIRT could optimize Hepatitis C treatment strategies.
    • Improved treatment responses can lead to better patient outcomes and reduced disease progression.